Three webinars from A.S.K, PCM Scientific's medical education programme, took place across November 2021. With each expert-led webinar providing in-depth discussions around the adaptation and usage of biosimilars medication in the treatment of patients with cancer.
Following the success of the three live webinars in November, a 10-chapter educational handbook was developed and is available to download on the website. This handbook closely investigates the use of in monoclonal antibody biosimilars to promote best clinical practice of treating patients with solid tumours.
ASK consists of dynamic, interactive, and multi-format educational activities, and in 2022 the website will feature the 10 learning chapters, a library of 30 abstracts, local guideline summary documents, and an archive of the three webinars. All educational resources will be translated into French, German, Italian, Spanish and Japanese. This programme specifically targets clinicians in Western Europe, Canada and Japan. Other members of the multidisciplinary team are also encouraged to make use of these resources.
The programme’s resources will be marketed through paid social media campaigns, newsletters and online ads through the ASK social media platforms and with the help of faculty and worldwide societies. Marketing avenues also include our media brands Hospital Pharmacy Europe and Hospital Healthcare Europe.